TITAN PHARMACEUTICALS INC
10-Q, EX-27.1, 2000-08-14
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: TITAN PHARMACEUTICALS INC, 10-Q, 2000-08-14
Next: ONHEALTH NETWORK CO, 10-Q, 2000-08-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS INCLUDED IN THE COMPANY'S FORM 10-Q
FOR THE PERIOD ENDED JUNE 30, 2000, AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                           6,278
<SECURITIES>                                    76,237
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                82,982
<PP&E>                                             817
<DEPRECIATION>                                     302
<TOTAL-ASSETS>                                  83,513
<CURRENT-LIABILITIES>                            1,579
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       146,017
<OTHER-SE>                                    (65,324)
<TOTAL-LIABILITY-AND-EQUITY>                    83,513
<SALES>                                              0
<TOTAL-REVENUES>                                   616
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                 7,311
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                (6,071)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (6,071)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (6,071)
<EPS-BASIC>                                     (0.24)
<EPS-DILUTED>                                   (0.24)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission